Clinical Trial: Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Asthma
Study Type: INTERVENTIONAL
Official Title: A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma
Brief Summary:
The purpose of this study is to investigate the effect on airway inflammation and JAK1-associated signalling pathways of AZD4604 compared with placebo in participants with moderate-to-severe asthma.Study details include:The study duration for each participant will be approximately 10 weeks.The duration of IMP administration will be approximately 4 weeks.
Read more